GlaxoSmithKline (GSK) forecast that 2019 sales of its shingles vaccine would be more than £1bn (€1.1bn) but the drugmaker’s shares slipped on concerns about its pharmaceutical business and free cash flow.

Previously unseen details of a medical trial by Glaxo in 1974 at a Cork mother and baby home have generated a whole new series of questions for the nuns and the companies involved, writes Conall Ó Fátharta.

GlaxoSmithKline reported its first increase in quarterly profit since 2013, helped by sales of its HIV medicines and a weakening sterling.

Uncertainty over the future of Britain remaining in the EU has big pharmaceutical manufacturers in Ireland, and around the world, worried.

A copyright suit between Walt Disney and a California resident has been settled, according to a June 24 court filing.

A major pharmaceutical company is seeking an injunction preventing the roll-out by a rival of an inhaler for asthmatics over alleged infringement of its trademark.

James Reilly, the children’s minister, has not made contact with GlaxoSmithKline in relation to the, previously undisclosed, fifth vaccine trial carried out on infants here in the 1960s.

GlaxoSmithKline Plc will cut several hundred jobs from its US workforce as part of the drugmaker’s efforts to reduce costs by £1bn (€1.27bn).

The urgent need for greater openness and accountability in the murky world of vaccine trials is borne out by today’s front page report showing the public was kept in the dark about a previously unknown trial carried out on Irish children during the 1960s.

Glaxo Smith Kline vice-president, Bernadette Doyle’s love of science was nurtured in primary school by a nun who taught to learn through discovery, she tells Arlene Harris

GlaxoSmithKline, battered by weak US drug sales and a bribery scandal inChina, set out a bold recovery plan yesterday, including an initial public offering of part of its fast-growing HIV and AIDS drugs business.

A law firm representing the bulk of children and adults who developed narcolepsy in the wake of being vaccinated against swine flu is not expecting to go to trial before March 2016.

A British man and his American wife have been handed prison terms on charges of illegally trading in the personal details of Chinese citizens after they testified that they bought such information to help companies combat fraud.

GlaxoSmithKline’s difficult year continued today as shares tumbled on a warning that it no longer expects to improve a key measure of earnings.

Chinese authorities have formally indicted two corporate investigators, a Briton and an American, for allegedly illegally obtaining and selling private information.

GlaxoSmithKline and Swiss rival Novartis are to create a consumer healthcare powerhouse as part of a string of deals in the pharmaceuticals sector today.

Drugs giant GlaxoSmithKline has launched an investigation into allegations of corruption in Iraq just months after becoming embroiled in a major bribery scandal in China.

GlaxoSmithKline Ireland’s own quality control team ignored test results that could have indicated drug contamination at the Cork plant as far back as 2011, according to the US drugs watchdog.

Drugs giant GlaxoSmith-Kline will stop paying for doctors to attend medical conferences and scrap some sales targets as it seeks to mend its reputation in the wake of a damaging scandal over multimillion-pound bribery claims in China.

Drugs giant GlaxoSmithKline will stop paying for doctors to attend medical conferences and scrap some sales targets as it seeks to mend its reputation in the wake of a damaging scandal over multimillion-euro bribery claims in China.

Drugs giant GlaxoSmithKline has raised around £425m from the sale of shares in South Africa’s Aspen Pharmacare.

Drugs giant GlaxoSmithKline has revealed a corruption probe in China sent sales of pharmaceuticals and vaccines in the country plummeting 61%.

Hopes of an international compromise on the Syrian crisis fuelled gains on the FTSE 100 Index as oil prices also eased back from recent highs.

Popular soft drinks brands Lucozade and Ribena are to be swallowed by Orangina Schweppes owner Suntory for €1.6bn.

Soft drinks brands Lucozade and Ribena could be bought by Japan’s Suntory Beverage & Food within days in a deal worth more than £1bn.

GlaxoSmithKline Plc has won US regulatory approval for a daily pill against the deadly HIV infection that was developed by ViiV Healthcare Ltd, its joint venture with two other drugmakers.

The head of drugs giant GlaxoSmithKline has sought to blame a handful of senior managers for corruption allegations it is facing in China and said the company itself had been a victim of their actions.

Drug maker GlaxoSmithKline, under investigation on suspicion its employees bribed Chinese doctors, has admitted some of its executives may have broken the law.

Drinks brands Lucozade and Ribena were today reported to be a £1bn takeover target for the owner of Irn-Bru.

Multi-national company GlaxoSmithKline was today caught up in an investigation by Chinese authorities into alleged bribery of hospitals and doctors by employees of the pharmaceutical giant.

Elan agreed to pay $1bn (€770m) for a share of the royalties on new drugs from Theravance as it tries to persuade shareholders to spurn a takeover offer by Royalty Pharma.

GlaxoSmith Kline, a major manufacturer of anti-diabetes drugs, has decided to sell its Lucozade and Ribena brands — a move that coincides with the release of a major study that shows drinking one can of fizzy drinks a day increases the likelihood of contracting diabetes by 20%.

Household drinks brands Lucozade and Ribena are set to be put up for sale for as much as €1.1bn, it was reported today.

Drugs giant GlaxoSmithKline was today accused by the UK's competition watchdog of paying off firms to delay the launch of cheap versions of its antidepressant treatment in a move that denied the British National Health Service “significant” cost savings.

Up to 94 staff are to lose their jobs in GlaxoSmith-Kline after the company announced it was moving a division to Britain.

GlaxoSmithKline has put iconic drinks Lucozade and Ribena under review as it looks for the “best ways to ensure their continued growth”.

Drugs giant GlaxoSmithKline today called on European governments to halt aggressive price cuts on medicines or suffer “unintended consequences”.

GlaxoSmithKline warned that sales in 2012 would be flat as pressure on drug prices intensifies in Europe, due to government austerity measures aimed at curbing healthcare bills.

A US judge has signed off an agreement by British drug maker GlaxoSmithKline to pay $3bn for criminal and civil violations involving 10 drugs that are taken by millions of people.

It has been a chaotic week for investors, with shocks coming from major companies on both side of the Atlantic.

Drugs firm GlaxoSmithKline will pay $3bn (€2.4bn) in fines after admitting to the largest healthcare fraud in US history.

Pharmaceutical giant GlaxoSmithKline has agreed to plead guilty and pay $3bn (€2.38bn) to resolve criminal and civil allegations that it illegally promoted prescription drugs and failed to report safety data, the US said.

Drugs giant GlaxoSmithKline said it was disappointed that an offer worth £1.6bn (€1.94bn) for US-based Human Genome Sciences (HGS) has been rejected.

Pharmaceutical giant GlaxoSmithKline has said it has a health portfolio of new products in the pipe-line that will reverse their falling sales.

GlaxoSmithKline today agreed to one of the largest fines ever levied on a pharmaceuticals firm to settle a trio of long-running disputes with the US government.

Drugs giant GlaxoSmithKline is to “rev up” its research and manufacturing operations through a tie-up with Formula 1 team McLaren.

Drug maker GlaxoSmithKline today said a pipeline of new products would help sustain growth as it revealed a rise in underlying sales.

Pharmaceuticals giant GlaxoSmithKline unveiled a deal today to buy the company behind Maximuscle protein shakes used by rugby player Gavin Henson, cricket star Stuart Broad and footballer Jermaine Jenas.

IRISH pharmaceutical group, Elan has named former Glaxo Wellcome chief executive, Robert (Bob) Ingram as its next chairman.